Target intelligence / Profile preview

Histone H1.5 (H1.5)

Target
H1.5
Molecular classification
Histone, Chromatin structural protein, Linker histone, Other
01

Overview

Histone H1.5 is a member of the linker histone H1 family, which binds to DNA at the entry and exit sites on nucleosomes and stabilizes the structure of chromatin by promoting the compaction of chromatin fibers[2][3][4][6]. Unlike the core histones (H2A, H2B, H3, H4) that form the nucleosome core, linker histones like H1.5 do not make up the nucleosome "bead" but instead help organize and stabilize higher-order chromatin structures, influencing processes such as transcription, replication, and splicing[2][3][4]. H1.5 is particularly notable for its relatively long C-terminal domain, which is rich in positively charged residues and confers a higher affinity for chromatin, contributing to its longer residence time in chromatin compared to other H1 subtypes[1]. H1.5 has been shown to play a specific regulatory role in alternative mRNA splicing in differentiated cells by binding over splice sites, affecting exon inclusion and RNA polymerase II pausing at splice junctions[1]. The family of linker histones, including H1.5, mediates chromatin folding and modulates accessibility of DNA to transcription factors and other regulatory proteins, thereby exerting both structural and regulatory control over genetic information in eukaryotic cells[2][3][4][6]. At present, Histone H1.5 is not considered a direct therapeutic target or established biomarker, nor are there known drugs that selectively target it. Altered expression of H1.5 and other H1 variants has been observed in various cancers and during cell differentiation, suggesting possible disease associations but not direct druggability[1][6].

Other names
H1-5H1F5HIST1H1BH1bH1s-3Histone H1aHistone H1bHistone H1s-3H1H1BH1 histone family, member 5histone 1histone cluster 1 H1 family member b
02

Biological functions

Chromatin compaction and foldingRegulation of transcriptionRegulation of alternative splicingHigher-order chromatin organizationModulation of gene expression through chromatin architecture
03

Disease associations

Cancer (altered expression linked to changes in chromatin structure and differentiation)Other (possible roles in cell differentiation and tumorigenesis)

Beyond the preview

Go deeper on Histone H1.5 (H1.5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone H1.5 (H1.5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call